What brief information should I include in a presentation about the imaging modalities for the kidneys, ureters, and urinary bladder—specifically ultrasound (USS), non‑contrast computed tomography of the kidneys‑ureters‑bladder (CT KUB), contrast‑enhanced CT urography (CT urography), and magnetic resonance imaging (MRI)—including which modality is first‑line?

Imaging Modalities for the Urinary System: Presentation Guide

First-Line Modality

CT Urography (CTU) is the imaging study of choice for comprehensive evaluation of the kidneys, ureters, and bladder, demonstrating 96% sensitivity and 99% specificity for detecting urothelial malignancy 1. However, the first-line modality depends on your clinical scenario:

• For suspected stones (renal colic): Non-contrast CT KUB is first-line
• For hematuria workup: CT Urography is first-line
• For surveillance/pregnancy/pediatrics: Ultrasound is first-line

---

1. Ultrasound (USS) of Kidneys and Bladder

Key Points for Your Presentation:

• Advantages:

  • No radiation exposure
  • Cost-effective
  • Readily available at bedside
  • Excellent for detecting hydronephrosis (up to 100% sensitive) 2
  • Good for monitoring known stone disease

• Limitations:

  • Lower sensitivity for detecting stones: only 24-57% overall compared to CT 2
  • Poor detection of ureteral stones (61% sensitivity) 2
  • Tends to overestimate stone size, especially for stones ≤5 mm 2
  • Cannot reliably detect small urothelial lesions
  • Operator-dependent

• Clinical Role:

  • First-line in pregnancy and pediatrics
  • Surveillance of known stone disease
  • Initial evaluation when radiation avoidance is priority
  • Not recommended as first-line for hematuria workup 1

---

2. Non-Contrast CT KUB (Kidney-Ureter-Bladder)

Key Points for Your Presentation:

• Advantages:

  • Gold standard for acute stone disease 2
  • 96-100% sensitivity and specificity for stones 2
  • Detects stones of all compositions (except indinavir)
  • Fast acquisition time
  • Shows secondary signs of obstruction
  • Can identify alternative diagnoses

• Limitations:

  • Radiation exposure (mitigated by low-dose protocols)
  • No functional information
  • No IV contrast = limited soft tissue characterization
  • Cannot evaluate urothelial lesions adequately

• Clinical Role:

  • First-line for suspected urolithiasis/renal colic 2
  • Acute flank pain evaluation
  • Stone surveillance when size/location assessment needed

• Technical Note:

  • Scan range should be from T10 vertebral body to pubic symphysis to minimize overscanning 3

---

3. CT Urography (CTU)

Key Points for Your Presentation:

• Protocol Components:

  • Unenhanced phase (stone detection)
  • Nephrographic phase (renal parenchyma evaluation)
  • Excretory phase (≥5 minutes post-contrast for ureter/bladder opacification)
  • Thin-slice acquisition with multiplanar reconstructions

• Advantages:

  • Imaging study of choice for hematuria 1
  • 96% sensitivity, 99% specificity for urothelial malignancy 1
  • 99.6% accuracy for upper tract lesions (kidneys/ureters) 1
  • 97.2% accuracy for lower tract lesions (bladder) 1
  • Evaluates both nephrogenic and urogenic causes
  • Superior to all other modalities for comprehensive urinary tract assessment

• Limitations:

  • Higher radiation dose than non-contrast CT
  • Requires IV contrast (contraindicated in severe renal impairment)
  • Contrast allergy risk
  • More expensive than ultrasound

• Clinical Role:

  • First-line for hematuria evaluation 1
  • Suspected urothelial malignancy
  • Complex stone disease requiring anatomic detail
  • Pre-operative planning

---

4. MR Urography (MRU)

Key Points for Your Presentation:

• Protocol Options:

  • Unenhanced: Heavily T2-weighted sequences (fluid-sensitive)
  • Contrast-enhanced: Includes corticomedullary, nephrographic, and excretory phases

• Advantages:

  • No ionizing radiation
  • Excellent soft tissue contrast
  • Comparable accuracy to CT for renal mass characterization 1
  • Option for patients with contrast allergy (unenhanced protocol)

• Limitations:

  • Decreased spatial resolution compared to CTU 1
  • Poor detection of small non-obstructive stones 1
  • Difficult to visualize small urothelial lesions 1
  • For acute stones: only 50% detection rate vs 91% for CT 2
  • Expensive
  • Longer acquisition time
  • Often requires sedation in children
  • Limited availability

• Clinical Role:

  • Alternative when CT contraindicated (pregnancy after first trimester, severe contrast allergy)
  • Renal mass characterization
  • Pediatric patients when ultrasound insufficient
  • Not first-line for any urinary tract indication 1

---

Clinical Algorithm Summary

For Your Presentation Flow:

Acute Flank Pain/Suspected Stones:

1. Non-contrast CT KUB (first-line)
2. Ultrasound (if pregnant, pediatric, or radiation concern)

Hematuria Workup:

1. CT Urography (first-line) 1
2. MRU (only if CT contraindicated)
3. Ultrasound alone is inadequate 1

Stone Surveillance:

1. Ultrasound (first-line for monitoring)
2. Low-dose CT KUB (if size/location critical)

Special Populations:

• Pregnancy: Ultrasound first, MRU without contrast if needed 1
• Pediatrics: Ultrasound first-line 4
• Renal insufficiency: Unenhanced MRU or non-contrast CT

---

Common Pitfalls to Mention

• Don't use plain KUB radiographs as first-line - only 29% sensitive for stones overall, 72% for large stones 2
• Don't use ultrasound alone for hematuria - misses urothelial lesions and small stones 1
• Don't order MRU when CTU is available - inferior visualization and diagnostic confidence 1
• Avoid gadolinium in pregnancy - safety uncertain 1